pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
Vaccine for Triple-Negative Breast Cancer
Triple-Negative Breast Cancer (TNBC)
Flow Pharma Inc
Preclinical
Vaccine to Target IL15, IL15RA and CD80 for Acute Myeloblastic Leukemia
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
University of California San Francisco
Marketed
Vaxneuvance
Vaxneuvance
Streptococcal Pneumonia
$MRK
Merck & Co., Inc.
← prev
page 148 of 231
next →
131
Pain
89
Neurology
1
Phase 3
VerorabVax
Rabies
$SNY
Sanofi
Preclinical
Viral Diseases
Coronavirus Disease 2019 (COVID-19)
Max Biopharma Inc
Marketed
Vyvanse
Vyvanse (lisdexamfetamine)
ADHD, binge eating disorder
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Phase 1
WCK-6777
Pyelonephritis
Wockhardt Ltd
Preclinical
WOREE/SCAR12 (WWOX Deficiency)
Epileptic Encephalopathy
Mahzi Therapeutics Inc
Phase 2
WP-1066
Glioblastoma Multiforme (GBM)
$MBRX
Moleculin Biotech, Inc.
Preclinical
WP-1096
Coronavirus Disease 2019 (COVID-19)
$MBRX
Moleculin Biotech, Inc.
Preclinical
WP-1097
Coronavirus Disease 2019 (COVID-19)
$MBRX
Moleculin Biotech, Inc.
Preclinical
WSD-0329
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
Phase 1
WSD-0628
Astrocytoma
Wayshine Biopharma Inc
Phase 2
WSD-0922
Non-Small Cell Lung Cancer
Wayshine Biopharma Inc
Preclinical
WSD-1227
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
Phase 2
WTX-330
Colorectal Cancer
$HOWL
Werewolf Therapeutics, Inc.
Phase 2
WVE-007
Obesity
$WVE
Wave Life Sciences Ltd.
Phase 2
WVEN-531
Duchenne Muscular Dystrophy
$WVE
Wave Life Sciences Ltd.
Phase 2
Wiskott-Aldrich Syndrome
Wiskott-Aldrich Syndrome
Genethon SA
Preclinical
X-004
Hemorrhagic Cystitis (Haemorrhagic Cystitis)
Ixaltis
Phase 1
XB-010
Endometrial Cancer
$EXEL
EXELIXIS, INC.
Phase 1
XB-371
Solid Tumor
$EXEL
EXELIXIS, INC.
Phase 1
XB-628
Solid Tumor
$EXEL
EXELIXIS, INC.
Preclinical
XBIO-020
Hematological Tumor
$XBIO
Xenetic Biosciences, Inc.
Preclinical
XDC Conjugate Drugs
Unspecified
Aojin Life Sciences (Yixing) Co Ltd
XENON, XE-133
XENON, XE-133 (XENON)
no indication
CURIUM
Phase 3
XG-005
Post-Operative Pain
Xgene Pharmaceutical Inc
Preclinical
XJ-MK-001
Thrombocytopenia
HemaCell Biotechnology Inc
Phase 1
XKH-002
Solid Tumor
Zhejiang Xinkanghe Biomedical Technology Co Ltd
Phase 1
XL-309
Fallopian Tube Cancer
$EXEL
EXELIXIS, INC.
